(openPR) - Munich / Morristown, NJ – November 30, 2008 – Definiens, the number one Enterprise Image Intelligence™ company, is introducing a new computer-aided detection (CAD) application at RSNA 2008 that allows radiologists to identify and analyze lymph nodes volumetrically and compare them over time. Definiens LymphExpert™ enables radiologists to rapidly and accurately track lymph nodes of interest, facilitating earlier detection of the metastatic spread of cancer.
Lymph nodes play a critical role in the assessment of the spread of cancer through the
lymphatic system and the staging of almost all types of cancer and therapy control. The earlier the metastatic spread of cancer can be detected, the higher the chances are for successful treatment. “Identifying lymph nodes, which often blend into surrounding tissue, is a challenging undertaking,” said Frank-P. Klein, Vice President, Medical Imaging at Definiens. “But we are keen to apply our technology to the most difficult tasks facing medical imaging professionals. This technology has the potential to streamline oncology diagnostics.”
Unlike most competing technologies, which are pixel-based, Definiens Cognition Network Technology® is context-based. It examines objects in relation to one another and emulates human cognitive processes to extract intelligence from images. Definiens LymphExpert™ is built on this unique technology and is the first medical imaging application released by Definiens. Designed to support radiologists’ analysis of lymph node volume over time, it will also enable them to analyze standard parameters required by RECIST and WHO in a consistent, fast and reproducible manner.
Definiens’ entrance into the medical imaging arena has been met with excitement by researchers and clinicians. Peter Herzog, MD, a member of the Clinical Radiology Department at the University Hospital of Munich, praised Definiens’ technology, saying, “Definiens’ ability to not only measure the size of lymph nodes, but also monitor their growth and development will have profound implications for the oncology community.”
Definiens LymphExpert™ will be introduced at RSNA and made commercially available in Europe in early 2009.
Ricochet PR
55 Broadway, 7th Floor
New York, NY
10006
About Definiens
Definiens is the number one Enterprise Image Intelligence company for analyzing and interpreting images on every scale, from microscopic cell structures to satellite images. The Definiens Cognition Network Technology®, developed by Nobel Laureate Prof. Gerd Binnig and his team, is an advanced and robust context-based technology designed to fulfill the image analysis requirements of the Medical, Life Science, and Earth Science markets. The technology is modeled on the powerful human cognitive perception processes to extract intelligence from images. Definiens provides organizations with faster image analysis results, allowing deeper insights enabling better business decisions. The company is headquartered in Munich, Germany and has offices in the United States. Further information is available at www.definiens.com.
Definiens, Definiens Cellenger, Definiens Cognition Network Technology, Definiens eCognition, Enterprise Image Intelligence and Understanding Images are trademarks or registered trademarks of Definiens.
Definiens in Medical Imaging
By automating image analysis, Definiens supports healthcare providers in analyzing and interpreting vast numbers of digital images accurately and consistently. Definiens improves the analysis of tissue samples and non-invasive imaging, enabling translational medicine - from early diagnosis to personalized treatment.
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
Newsfeed
